Craig Mosman
@craig-mosman-idaho
As the Vice President of Business Development of Seek Labs, Craig Mosman oversees the company's various operations, including its offices in the US, Vietnam, and Italy. He also acts as the president of Kirkland Bio. As a result, he is focused on investing in early- stage biotechnology companies that are developing portable, fast diagnostic tests for healthcare.
Due to his work in developing countries, Craig was greatly affected by the inequalities in the healthcare system in different regions. For instance, in developing nations, patients often wait long periods to receive treatment and diagnosis. Many of the preventable deaths that occur due to these issues can be attributed to the lack of proper diagnostic methods. As a result, Craig Mosman of Idaho decided to fund and develop a technology that could allow healthcare providers to quickly diagnose and treat illnesses.
Since the outbreak of the pandemic, Craig has been more focused on developing new diagnostic methods that can help healthcare providers identify and treat diseases. He believes that point-of care testing will play a vital role in the future. Having the ability to test for infectious diseases at the point of care is very beneficial for rural areas and resource-constrained regions. It can help prevent infections from spreading and improve the quality of care for patients.
One of the most important factors that has been identified as a potential game-changer in the field of infectious disease is the development of a new gene-editing tool known as CRISPR. This technology is capable of precisely cutting and deleting DNA or RNA, and it can also alter certain genes. Through its partnership with researchers, Seek Labs is currently working with scientists to develop a potential new therapeutic for treating viral infections.
Due to his work in developing countries, Craig was greatly affected by the inequalities in the healthcare system in different regions. For instance, in developing nations, patients often wait long periods to receive treatment and diagnosis. Many of the preventable deaths that occur due to these issues can be attributed to the lack of proper diagnostic methods. As a result, Craig Mosman of Idaho decided to fund and develop a technology that could allow healthcare providers to quickly diagnose and treat illnesses.
Since the outbreak of the pandemic, Craig has been more focused on developing new diagnostic methods that can help healthcare providers identify and treat diseases. He believes that point-of care testing will play a vital role in the future. Having the ability to test for infectious diseases at the point of care is very beneficial for rural areas and resource-constrained regions. It can help prevent infections from spreading and improve the quality of care for patients.
One of the most important factors that has been identified as a potential game-changer in the field of infectious disease is the development of a new gene-editing tool known as CRISPR. This technology is capable of precisely cutting and deleting DNA or RNA, and it can also alter certain genes. Through its partnership with researchers, Seek Labs is currently working with scientists to develop a potential new therapeutic for treating viral infections.